August 4, 2026
4m 31s
Share:
Interview conducted at the AMCPER 2026 Congress — Expo Santa Fe, Mexico City Interviewer: Dr. Fabrizio Verdini, Biobarica Medical Liaison
Some data needs no interpretation. Dr. Salvador García, a plastic surgeon in private practice at Hospital Jardines in Guadalajara, Jalisco, has been incorporating the hyperbaric chamber into his post-aesthetic surgery protocol for three years. And when asked what the difference was, he answers with numbers: out of every 100 patients operated on, it used to be common to see dehiscence and wound complications. Today, 99 out of 100 leave without any issues. That is the before and after.
Three Years of Protocol, Zero Improvisation
Dr. García did not come to hyperbaric therapy out of curiosity or trend-following. He arrived with a concrete clinical problem — the frequency of complications in postsurgical wounds — and found in the hyperbaric chamber a systematic, measurable response.
For three years, his standard protocol for aesthetic surgery patients has included:
- 5 preoperative sessions, to prepare tissues before the procedure
- 10 postoperative sessions, to accelerate healing and reduce complications
Patient selection prioritizes those with known risk factors: active smoking, a history of poor wound healing, or any condition that compromises perfusion and the tissue's regenerative response. But the medium-term goal is for all aesthetic surgery patients to receive the therapy, regardless of their risk profile.
This universalization of the protocol is the logic of someone who has already seen the results and does not want to leave any patient outside that benefit.
The Number That Says It All
When Dr. Fabrizio Verdini, Biobarica's medical liaison, asks Dr. García what the concrete difference was between operating with and without the hyperbaric chamber, the answer is direct:
"Before hyperbaric medicine, out of roughly 100 patients we operated on in a given surgery, it was very common to see some dehiscence or wounds that struggled to heal. After using the hyperbaric chamber, that practically reversed: out of 100 patients, maybe one has a wound issue. The other 99 come out perfectly fine — faster recovery, less inflammation, and better scarring."
99 out of 100. That number summarizes three years of practice, dozens of protocols, and thousands of sessions. And it does so with the precision of a physician who keeps records, compares before and after, and can state with certainty that the change was not gradual or marginal: it was radical.
Hyperbaric therapy acts on the physiological mechanisms that explain that result: it increases tissue oxygenation, stimulates collagen synthesis, reduces the inflammatory response, and improves perfusion at the wound edges — exactly where dehiscence and necrosis originate.
The Decision to Choose Biobarica: Certifications as the Starting Point
Dr. García is candid about the process that led him to choose Biobarica. At first, there was uncertainty. A device coming from abroad, a technology he did not know in detail, an investment that required conviction.
"At first there is some uncertainty because you don't know it — it was a device coming from abroad. But giving it a chance, seeing that it has certifications like FDA, COFEPRIS, and in many countries around the world, that gives you some confidence."
The path Dr. García describes is the same one many physicians walk before incorporating new technology into their practice: first the doubt, then the research, then the evidence that tips the balance. In his case, the international certifications — FDA, COFEPRIS, ANMAT, and those from dozens of countries — were the first trust filter. The chamber's performance in daily practice was the definitive confirmation.
This point is key, and Dr. Verdini emphasizes it during the interview: before acquiring any hyperbaric chamber, reviewing the device's certifications is not a bureaucratic formality. It is a clinical safety decision. The Biobarica Revitalair chamber holds COFEPRIS — Mexico's regulatory certification — as well as FDA, CE, and approvals from more than 60 countries.
The Right Atmospheres: No More and No Less Than What the Patient Needs
One of the most practical points in Dr. García's testimony concerns the tolerability of the treatment. In hyperbaric medicine, the atmospheres — the pressure at which oxygen is administered — determine both therapeutic efficacy and the patient's experience.
"Sometimes we get a little scared about going too deep into the atmospheres the hyperbaric chamber operates at, but you have to identify what you specifically need it for. For my type of surgery, the atmospheres that Biobarica offers are more than sufficient for patients to get a good result."
And he adds a point that speaks directly to protocol adherence:
"In practice, it has fewer side effects and patients tolerate it well. I have seen cases where patients feel that ringing in the ear or can't tolerate as much pressure in other devices and end up dropping out."
Tolerability is not a cosmetic detail: it is a clinical factor. A patient who abandons the protocol halfway through does not achieve the expected results. Hyperbaric medicine only works when the protocol is completed. And a device that patients tolerate well is a device that guarantees adherence.
Advice for the Colleague Who Still Has Doubts
When Dr. Verdini asks what he would say to an undecided colleague — from any specialty, not just plastic surgery — Dr. García offers concrete guidance:
"You have to identify what you specifically need it for. For what we commonly do, the atmospheres Biobarica offers are more than sufficient."
The implicit recommendation is clear: do not overestimate the complexity of the decision. The hyperbaric chamber does not require special infrastructure, does not demand highly specialized staff, and the atmospheres Biobarica offers cover the most common applications across plastic surgery, traumatology, neurology, angiology, and other specialties.
The Biobarica Global System supports that integration with specialty-validated clinical protocols, ongoing training, patient management software, and remote technical support — all available from day one, so physicians don't have to navigate any part of the process alone.
Conclusion: Evidence Built Session by Session
What Dr. Salvador García describes from Guadalajara is not a promise or a hypothesis. It is the result of three years of systematic practice, a defined protocol, selected patients, and clinical records that back every statement.
99 out of 100 patients with no wound complications. Less inflammation. Better scarring. Faster recovery. And a physician who started with uncertainty and today tells his colleagues to join the Biobarica family.
That is the evidence that matters: the kind built case by case, session by session, in a real practice, with real patients.
If you are a physician and want to learn how to integrate the hyperbaric chamber into your practice, contact our team and a Biobarica specialist will guide you from the very first step.
Interview conducted at AMCPER 2026, Plastic Surgery Congress, Expo Santa Fe, Mexico City. Interviewer: Dr. Fabrizio Verdini, Biobarica Medical Liaison.
Share:
Related
